Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Rigo

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
Genomics|February 4, 2015
Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7John F Staropoli, Huo Li, Seung J Chun, et al.
EMBO Molecular Medicine|September 10, 2013
Pathological impact of SMN2 mis-splicing in adult SMA miceKentaro Sahashi, Karen K Y Ling, Yimin Hua, et al.
Hepatology (Baltimore, Md.)|April 6, 2023
ASO silencing of a glycosyltransferase, Poglut1 , improves the liver phenotypes in mouse models of Alagille syndromeNima Niknejad, Duncan Fox, Jennifer L Burwinkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2018
Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decayAndrew D Nguyen, Thi A Nguyen, Jiasheng Zhang, et al.
Nature|April 14, 2017
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 miceLindsay A Becker, Brenda Huang, Gregor Bieri, et al.
Nature Communications|December 23, 2020
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progressionKung-Chi Chang, Sarah D Diermeier, Allen T Yu, et al.
Cells|August 11, 2023
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS AstrocytesCarola Torazza, Francesca Provenzano, Elena Gallia, et al.
Annals of Neurology|January 17, 2020
Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet SyndromeGuy M Lenk, Paymaan Jafar-Nejad, Sophie F Hill, et al.
Lancet (London, England)|December 13, 2016
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
Neuron|July 17, 2020
G<sub>4</sub>C<sub>2</sub> Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTDAlyssa N Coyne, Benjamin L Zaepfel, Lindsey Hayes, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Genomics|February 4, 2015
Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7John F Staropoli, Huo Li, Seung J Chun, et al.
EMBO Molecular Medicine|September 10, 2013
Pathological impact of SMN2 mis-splicing in adult SMA miceKentaro Sahashi, Karen K Y Ling, Yimin Hua, et al.
Hepatology (Baltimore, Md.)|April 6, 2023
ASO silencing of a glycosyltransferase, Poglut1 , improves the liver phenotypes in mouse models of Alagille syndromeNima Niknejad, Duncan Fox, Jennifer L Burwinkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2018
Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decayAndrew D Nguyen, Thi A Nguyen, Jiasheng Zhang, et al.
Nature|April 14, 2017
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 miceLindsay A Becker, Brenda Huang, Gregor Bieri, et al.
Nature Communications|December 23, 2020
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progressionKung-Chi Chang, Sarah D Diermeier, Allen T Yu, et al.
Cells|August 11, 2023
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS AstrocytesCarola Torazza, Francesca Provenzano, Elena Gallia, et al.
Annals of Neurology|January 17, 2020
Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet SyndromeGuy M Lenk, Paymaan Jafar-Nejad, Sophie F Hill, et al.
Lancet (London, England)|December 13, 2016
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
Neuron|July 17, 2020
G<sub>4</sub>C<sub>2</sub> Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTDAlyssa N Coyne, Benjamin L Zaepfel, Lindsey Hayes, et al.
Pageof 17